Ciencias de la Salud
Domaine de connaissance
ANGEL
COSME JIMENEZ
Chercheur/Chercheuse/a dans le période 2008-2010
Publications dans lesquelles il/elle collabore avec ANGEL COSME JIMENEZ (67)
2021
-
Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: Results of the european registry on h. pylori management (hp-eureg)
Antibiotics, Vol. 10, Núm. 9
-
European registry on helicobacter pylori management: Effectiveness of first and second-line treatment in Spain
Antibiotics, Vol. 10, Núm. 1, pp. 1-15
-
Follow-up study confirms the presence of gastric cancer dna methylation hallmarks in high-risk precursor lesions
Cancers, Vol. 13, Núm. 11
2019
-
Autoamputation of a polypoid carcinoma of the rectum
Gastroenterologia y Hepatologia, Vol. 42, Núm. 8, pp. 486-487
-
Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies
Helicobacter, Vol. 24, Núm. 1
-
Helicobacter pylori pathogenicity and primary antimicrobial resistance in Northern Spain
European Journal of Clinical Investigation, Vol. 49, Núm. 8
-
Short article: Hormone therapy for severe gastrointestinal bleeding due to multiple angiodysplastic lesions
European Journal of Gastroenterology and Hepatology, Vol. 31, Núm. 3, pp. 312-315
2018
-
Genetic variation analysis in a follow-up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14
International Journal of Cancer, Vol. 143, Núm. 11, pp. 2777-2786
2017
-
Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance
World Journal of Gastroenterology, Vol. 23, Núm. 18, pp. 3367-3373
-
Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs
United European Gastroenterology Journal, Vol. 5, Núm. 2, pp. 255-260
-
Triple synchronous gastric tumors: A rare combination diffuse adenocarcinoma, B-cell MALT lymphoma and large cell neuroendocrine carcinoma
Gastroenterologia y Hepatologia, Vol. 40, Núm. 10, pp. 675-677
2016
-
Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance
Helicobacter, Vol. 21, Núm. 1, pp. 29-34
-
Effect of pravastatin on the survival of patients with advanced gastric cancer
Oncotarget, Vol. 7, Núm. 4, pp. 4379-4384
-
Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: Results of the Spanish follow-up multicenter study
Journal of Gastroenterology and Hepatology (Australia), Vol. 31, Núm. 5, pp. 953-958
2015
-
Colorectal cancer in a second round after a negative faecal immunochemical test
European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 7, pp. 813-818
2014
-
Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions
European Journal of Gastroenterology and Hepatology, Vol. 26, Núm. 12, pp. 1380-1384
-
Effect of oral anticoagulants on the outcome of faecal immunochemical test
British Journal of Cancer, Vol. 110, Núm. 5, pp. 1334-1337
-
Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests
Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4
2013
-
Alcohol consumption on pancreatic diseases
World Journal of Gastroenterology, Vol. 19, Núm. 5, pp. 638-647
-
Effect of aspirin and antiplatelet drugs on the outcome of the fecal immunochemical test
Mayo Clinic Proceedings